Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Medical Services Advisory Committee. IncobotulinumtoxinA (XEOMIN), injection of, for blepharospasm, cervical dystonia (spasmodic torticollis) and post-stroke spasticity of the upper limb. Canberra: Medical Services Advisory Committee (MSAC). MSAC application 1379. 2014 Authors' objectives Blepharospasm is a chronic progressive disorder, defined as involuntary, sporadic or permanent eyelid closure resulting in significant visual disability.
Cervical dystonia (spasmodic torticollis) covers a spectrum of involuntary movements with abnormal posture of the head and shoulder/neck region.
Post-stroke spasticity of the upper limb imposes a considerable humanistic burden. It is not only painful, but is often associated with functional impairment in personal hygiene and dressing, necessitating the help of a family member or professional caregiver. Indexing Status Subject indexing assigned by CRD MeSH Botulinum Toxins, Type A; Muscle Spasticitys; Stroke; Upper Extremity Language Published English Country of organisation Australia English summary An English language summary is available. Address for correspondence MDP 106, GPO Box 9848, Canberra ACT 2601 AUSTRALIA Email: msac.secretariat@health.gov.au AccessionNumber 32015000450 Date abstract record published 07/04/2015 |